Pfizer's Next Blockbuster Drug Has Big Promise. We'll Find Out Monday How Much.

A highly anticipated presentation slated for Monday at the European Society of Cardiology Congress in Munich will reveal full results from a late-stage study on tafamidis in a rare, fatal condition called transthyretin cardiomyopathy.